期刊文献+

血府逐瘀汤对大鼠后肢缺血模型血管新生的影响 被引量:3

Angiogenesis Study of XFZYD on Limb Ischemic Model of Rat
下载PDF
导出
摘要 目的:探讨血府逐瘀汤对大鼠缺血后肢模型血管新生的影响。方法:采用白及微球悬液栓塞法制作大鼠后肢缺血模型,并在造模后第3天低位截肢,分别在截肢术后第36小时和第48小时取材肉芽组织,常规病理切片观察各组样本缺血修复情况并计数局部血管数量。结果:SD大鼠栓塞术后第1天即表现为肢体发绀、跛行或拖拽,持续加重;截肢术后36 h,常规剂量和高剂量药物组的血管数量明显高于生理盐水组,尤以高剂量药物差异显著;术后48 h常规剂量药物失效,高剂量药物的血管数量仍明显高于生理盐水组。结论:血府逐瘀汤能短期促进肉芽组织的血管新生和促进缺血组织修复。 Objective:To discuss the therapeutic angiogenic effects of Xuefu Zhuyu Decoction (XFZYD) on limb ischemic model of rat. Methods SD Rat ischemic limb model was established by embolization with Bletilla microsphere suspension, and got low amputation on the third day after injection of Bletilla microsphere, then took granulation tissues respectively on the 36th , 48th and 72th hour after amputation. Observe ischemia repair situation and count numbers of blood vessels by routine pathological section. Results The ischemic limb of model rat was characterized by cyanosis, limp or drag after the first day of embolization. 36 hours after amputation, vessel number of high and regular dose of XFZYD group were both obviously higher than that of saline group, especially the high dose group ; 48 hours after amputation, the regular dose group could not improve the vessel growth, but the vessel number of high dose group still significantly higher than the saline group. Conclusion XFZYD could shortly promote vessel growth in granulation tissues to improve repairment of ischemic tissue .
出处 《中国中医基础医学杂志》 CAS CSCD 北大核心 2014年第4期465-467,共3页 JOURNAL OF BASIC CHINESE MEDICINE
基金 北京市自然科学基金资助项目(BJ7122120)
关键词 白及微球栓塞剂 缺血模型 血府逐瘀汤 血管新生 Bletilla mierosphere embolization agent ischemic model Xuefu Zhuyu Decoction angiogenesis
  • 相关文献

参考文献4

二级参考文献26

  • 1邓冰湘,谭达全,张秋雁,王大安,刘新华,张玉生.血府逐瘀汤对急性心肌缺血大鼠的保护作用[J].中国中医药信息杂志,2005,12(4):38-39. 被引量:16
  • 2高冬,宋军,胡娟,林久茂,郑良朴,蔡晶,杜建,陈可冀.活血化瘀中药对鸡胚绒毛尿囊膜血管生成的影响[J].中国中西医结合杂志,2005,25(10):912-915. 被引量:72
  • 3孙剑涛,张峻峰,陈一心,王春明,王嵘.自制白芨液态栓塞剂栓塞兔动脉瘤模型研究[J].中国微侵袭神经外科杂志,2005,10(10):462-464. 被引量:5
  • 4Hynes RO. Integrins: bidirectional, allosteric signaling machines[J]. Cell, 2002,110(6) :673-687.
  • 5Mundel TM, Kalluri R. Type IV collagen-derived angiogenesis inhibitors[ J]. Microvase Res, 2007,74 ( 2 - 3 ): 85- 89.
  • 6Keeley EC, Mehrad B, Strieter RM. Cbemokines as mediators of neovascularization [J].Arterioscler Thromb Vasc Biol, 2008, 28 ( 11 ) : 1928- 1936.
  • 7Armstrong LC, Bornstein P. Thrombospondins 1 and 2 function as inhibitors of angiogenesis [ J ]. Malrix Biol, 2003, 22(1):63-71.
  • 8Kyriakides TR, Zhu YH, Smith LT, et al. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, and increased vascular density, and a bleeding diathesis [J]. J Cell Biol, 1998, 140(2):419-430.
  • 9Kopp HG, Hooper AT, Broekman M J, et al. Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization [ J ]. J Clin Invest, 2006, 116(12):3111-3113.
  • 10Dejana E, Orsenigo F, Lampugnani MG. The role of adherens junctions and VE-cadherin in the control of vascular permeability[J]. J Cell Sci, 2008,121 (pt13):2115- 2122.

共引文献100

同被引文献50

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部